Skip to main content
Research-supported

Pain lasting 4-72 hours if untreated

Headache episodes lasting between 4 and 72 hours when untreated — a defining temporal criterion of migraine, distinguishing it from tension-type headache and other headache disorders.

CategoryPain
Pain lasting 4-72 hours if untreated — health symptom
Reviewed by Ian Henderson · Advisor
26 March 2026

At a glance

Pain lasting 4-72 hours if untreated at a glance

What it is

Pain lasting 4–72 hours if untreated is the characteristic duration of a migraine headache episode.

Commonly experienced as

  • People experiencing pain lasting 4-72 hours often describe a rollercoaster of hope and frustration. You might find yourself thinking the pain is subsiding, only to have it return with renewed intensity. Many report trying various home remedies, changing positions frequently, or cancelling plans as they wait for relief.
  • The emotional toll is significant too. There's often anxiety about when the pain will end, worry about what might be causing it, and frustration with the impact on daily activities. Some people describe feeling isolated, especially if others don't understand the severity or duration of their discomfort. The unpredictability of these episodes can make planning difficult and affect confidence in your body's reliability.

Context

Patterns of Pain lasting 4-72 hours if untreated

A headache duration of 4–72 hours (in adults) when left untreated or unsuccessfully treated is one of the four core diagnostic criteria for migraine without aura, as defined by the International Headache Society (ICHD-3). Alongside unilateral location, pulsating quality, moderate-to-severe intensity, and associated nausea or photophobia/phonophobia, this temporal pattern distinguishes migraine from tension-type headache (which may last 30 minutes to 7 days but lacks associated features) and cluster headache (15 minutes to 3 hours). Understanding this criterion helps in self-identification and clinical diagnosis. The headache phase is one of four migraine phases: prodrome, aura (in migraine with aura), headache, and postdrome.

Could this be you

People commonly experience

Pain lasting 4-72 hours if untreated shows up differently for everyone. Browse by how it tends to be felt — these are common experiences, not a checklist or a diagnosis.

In the body2 common experiences
  • People experiencing pain lasting 4-72 hours often describe a rollercoaster of hope and frustration. You might find yourself thinking the pain is subsiding, only to have it return with renewed intensity. Many report trying various home remedies, changing positions frequently, or cancelling plans as they wait for relief.
  • The emotional toll is significant too. There's often anxiety about when the pain will end, worry about what might be causing it, and frustration with the impact on daily activities. Some people describe feeling isolated, especially if others don't understand the severity or duration of their discomfort. The unpredictability of these episodes can make planning difficult and affect confidence in your body's reliability.

Common experiences people describe — not a diagnostic checklist.

Explore next

Related conditions

Conditions people often explore alongside pain lasting 4-72 hours if untreated.

The Evidence

Evidence context

What the research says about headache lasting 4–72 hours, its role in migraine identification, and how it is managed.

Overall pictureHigh evidence

A defining feature of migraine with strong clinical grounding

A headache lasting 4–72 hours when untreated is one of four core ICHD-3 criteria for migraine without aura. This time-course pattern is well-established in research and helps distinguish migraine from other headache types.

  • When to seek urgent careSome headache patterns require immediate medical attention and should not be self-managed.

    A sudden, severe 'thunderclap' headache may indicate subarachnoid haemorrhage — seek emergency care immediately. Headache with fever, neck stiffness, or rash may suggest meningitis. New headache in someone over 50, or headache with progressive neurological symptoms or vision loss, requires prompt professional assessment.

  • How well-supported is this criterion?The 4–72 hour duration criterion is backed by decades of international headache research.

    The ICHD-3 classification is the global standard for headache disorders, and the 4–72 hour window is well-established as a distinguishing feature of migraine. Several acute care approaches — including triptans and NSAIDs — have good evidence for shortening attack duration. CGRP antagonists are newer agents with a growing but still-developing evidence base, and evidence varies by agent.

  • Where this fits in migraine assessmentDuration is one of several criteria used together to identify migraine — no single feature is sufficient alone.

    Migraine without aura requires at least five attacks meeting criteria for duration, location, quality, intensity, and associated symptoms. Duration alone does not confirm migraine. A qualified healthcare professional should assess the full picture, particularly for new, changing, or frequent headaches. NICE guidelines support a stratified approach to both acute and preventive management.

  • Important safety considerationsSome commonly used care approaches carry specific risks in migraine management.

    Opioids are not recommended for migraine — they can worsen central sensitisation and increase the risk of medication overuse headache. Triptans are not appropriate for haemiplegic or basilar migraine, or for people with significant cardiovascular conditions. Butterbur, sometimes used traditionally for migraine, carries hepatotoxicity concerns and should be used only under professional guidance.

  • Complementary approaches with evidenceSeveral non-pharmaceutical options have research support for migraine prevention.

    Acupuncture has moderate evidence for migraine prevention, recognised in both NICE and AHS frameworks. Magnesium supplementation has evidence for both prevention and acute support in migraine specifically. Riboflavin (B2) shows preventive benefit in some studies. For each of these, evidence quality differs, and NICE and AHS guidance positions them as adjuncts to — not replacements for — a professionally assessed migraine management plan.

  • When to involve a professionalFrequent, severe, or changing headaches benefit from professional evaluation.

    If headaches occur more than four days per month, significantly affect daily life, or are not responding to over-the-counter options, a healthcare professional can assess suitability for preventive strategies. Overuse of acute pain relief on ten or more days per month can itself cause more frequent headaches — a pattern worth discussing with a qualified practitioner.

Safety first

Staying safe

General, informational guidance — not diagnostic. A qualified practitioner can advise on your own situation.

  • Opioids for migraine are not recommended — worsen central sensitisation and increase medication overuse headache risk
  • Triptans are contraindicated in haemiplegic migraine, basilar migraine, and in those with significant cardiovascular disease

References

Evidence & Research

Educational sources that inform this overview. Inclusion is for context and does not imply endorsement.

  1. The International Classification of Headache Disorders, 3rd edition
  2. Complementary and integrative treatments for episodic migraine: a systematic review and meta-analysis
  3. Acupuncture for migraine prophylaxis: a systematic review and meta-analysis

Full citations are maintained by the Gyfts editorial team and reviewed periodically.

Keep exploring

Find Pain lasting 4-72 hours if untreated practitioners you can trust

Browse practitioners, explore honest overviews, and take what you learn to a conversation — at your own pace.